VTRS News and Press, Viatris Inc. From 06/13/24

2024-06-13 12:38:50 ET Summary Viatris presents a unique equation to prospective investors. The stock is cheap on a price to sales / price to earnings ratio, but the business has been shrinking. Debt is massive - but cash flow is strong, and divestitures have already earned &g...

2024-06-11 18:03:08 ET Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 09:20 AM ET Company Participants Scott Smith - CEO Theodora Mistras - CFO Philippe Martin - Chief R&D Officer Conference Call Participants ...

2024-06-11 14:46:20 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Regeneron Pharmaceuticals, Inc. (REGN) Management presents at Jefferies 2024 Global Healthcare Conference (Tran...

2024-06-07 10:57:58 ET Summary Since Richard Francis became CEO in early 2023, his 'Pivot to Growth' strategy has continued to bear fruit. On April 16, the FDA approved Selarsdi, a biosimilar of Stelara, which earned Johnson & Johnson about $2.45 billion in the first quarter o...

Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PITTSBURGH , June 7, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report its second quarter 2024 financial results on Thursday, August 8, 2024 , before the...

2024-06-06 14:12:06 ET Viatris Inc. (VTRS) Jefferies 2024 Global Healthcare Conference Call June 6, 2024 08:00 ET Company Participants Scott Smith - Chief Executive Officer Doretta Mistras - Chief Financial Officer Philippe Martin - Chief R&D Officer Co...

Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire PITTSBURGH , June 4, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Goldman Sa...

Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors PR Newswire PITTSBURGH , June 3, 2024 /PRNewswire/ -- Viatris Inc . (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, R...

Viatris to Participate in the Jeffries Global Healthcare Conference PR Newswire PITTSBURGH , May 31, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced the company will participate in the Jeffries Global Healthcare ...

2024-05-30 18:16:29 ET Summary Viatris Inc. reported Q1 2024 results in line with expectations, with a 2% decline in net sales. The company's EBITDA and free cash flow have been negatively impacted by declining sales, and its debt to EBITDA ratio remains high. Despite the low ...